US COVID-19 Fraud: Oleander Stops Viral Duplication, Oral Rinse Delivers 30-Second Cure
Executive Summary
Online claims and social media posts lead to warnings to Phoenix Biotechnology and Avila Herbals for claiming oleander homeopathic at 4X concentration can interfere with COVID-19 and other viruses’ duplication, and Rowpar Pharmaceuticals about a rapid cure provided by oral rinses and spray.
You may also be interested in...
US Agencies Warn Company Claiming Electromagnetic Nanoparticles ‘Eradicate’ COVID-19 Virus
Dallas-based Indigenous Products, which suggested online that its nebulizer-delivered electromagnetic silver nanoparticles could “eradicate” the novel coronavirus, is among the latest recipients of warning letters from the US FDA and/or FTC to firms making COVID-19 claims.
After US FDA Finds ‘Particularly Concerning’ GMP Problems, Homeopathic Firm Continues OTC Sales
A warning letter submitted by FDA Office of Regulatory Affairs’ Division of Pharmaceutical Quality Operations I in New Jersey notes that Homeocare Laboratories indicated to agency officials that it no longer is manufacturing OTC drugs.
FDA Adds Homeopathic Enforcement Details, Subtracts Compliance Policy Guide
Revised draft guidance identifies types of homeopathics posing "higher risks to public health." FDA withdraws 1988 compliance policy guide that allows homeopathic to be available even though they are not subject to pre-market approval or other review process agency imposes on all other drugs.